论文部分内容阅读
目的:评价应用康莱特注射液治疗老年晚期非小细胞肺癌的疗效及对其生活质量的影响。方法:对我院2012年1月至2013年12月收治的156例老年非小细胞肺癌患者的临床资料进行回顾性分析,患者静脉滴注200 m L康莱特注射液,1次/d,21 d为1个周期,两个周期后观察其疗效及不良反应。结果:患者治疗后的临床有效率为62.18%,治疗进展时间平均为(2.34±0.78)月,生活质量明显改善,差异有统计学意义(P<0.05)。结论:采用康莱特注射液治疗老年晚期非小细胞肺癌,能提高患者生活质量,不良反应轻微。
Objective: To evaluate the effect of Kanglaite injection on the quality of life in advanced non-small cell lung cancer (NSCLC). Methods: The clinical data of 156 elderly patients with non-small cell lung cancer admitted to our hospital from January 2012 to December 2013 were retrospectively analyzed. Patients were infused intravenously with 200 mL Kanglaite Injection once daily, d for a period of two weeks after the observation of its efficacy and adverse reactions. Results: The clinical effective rate of patients after treatment was 62.18%, the average time of treatment was (2.34 ± 0.78) months, and the quality of life was significantly improved. The difference was statistically significant (P <0.05). Conclusion: Kanglaite injection in the treatment of advanced non-small cell lung cancer in elderly patients, can improve the quality of life of patients with mild adverse reactions.